Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
ESR-14-11441
Funder:
AstraZeneca
Funded outputs count:
1
Funder award ID:
ESR-14-11441
OpenAlex ID:
G5975081735
Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study
2019
·
for the DARWIN-T2D Network
, G. P. Fadini
, et al.
·
Journal of Endocrinological Investigation
·
19
PDF
Show more works
View as search